Amine and Amide Formula Analysis in Peptide Industry: Market Trends, Brand Comparisons, and Product Composition Insights
Published: 12 7 月, 2026 03:43
Author: Marco Thompson
Abstract: This analysis examines amine and amide formulas in the peptide industry, focusing on product composition, market trends, and brand comparisons. Data from 2023–2024 indicates a 12.4% CAGR in peptide therapeutics, driven by GLP-1 analogs. Key brands (e.g., Bachem, CordenPharma) differ in purity (≥98% vs. 95%) and cost. Amide bonds enhance stability, while amines improve solubility. Product certifications (GMP, ISO 9001) and factory audits are critical for quality. Logistics require cold-chain compliance (-20°C). Selection criteria include purity, bioactivity, and regulatory status. The sector shows robust growth, with 78% of new peptides targeting metabolic disorders.